Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology Debt to Equity Ratio 2010-2025 | POAI

Current and historical debt to equity ratio values for Predictive Oncology (POAI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Predictive Oncology debt/equity for the three months ending March 31, 2025 was 0.00.
  
Predictive Oncology Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.01B $0.00B -41.25
2024-12-31 $0.01B $0.00B -25.54
2024-09-30 $0.01B $0.00B 2.81
2024-06-30 $0.01B $0.00B 1.59
2024-03-31 $0.01B $0.00B 1.62
2023-12-31 $0.01B $0.01B 0.74
2023-09-30 $0.01B $0.01B 0.56
2023-06-30 $0.01B $0.02B 0.43
2023-03-31 $0.01B $0.02B 0.35
2022-12-31 $0.00B $0.02B 0.18
2022-09-30 $0.00B $0.03B 0.12
2022-06-30 $0.00B $0.03B 0.09
2022-03-31 $0.00B $0.04B 0.08
2021-12-31 $0.00B $0.04B 0.09
2021-09-30 $0.00B $0.05B 0.07
2021-06-30 $0.00B $0.05B 0.07
2021-03-31 $0.00B $0.04B 0.12
2020-12-31 $0.01B $0.00B 3.94
2020-09-30 $0.01B $0.01B 1.06
2020-06-30 $0.02B $0.01B 1.35
2020-03-31 $0.02B $0.01B 1.42
2019-12-31 $0.01B $0.01B 0.99
2019-09-30 $0.01B $0.02B 0.54
2019-06-30 $0.01B $0.02B 0.45
2019-03-31 $0.01B $0.00B 71.67
2018-12-31 $0.00B $0.00B 68.33
2018-09-30 $0.00B $0.00B 0.79
2018-06-30 $0.00B $0.00B 0.19
2018-03-31 $0.00B $0.01B 0.15
2017-12-31 $0.00B $0.00B 0.35
2017-09-30 $0.00B $0.00B 0.53
2017-06-30 $0.00B $0.00B 0.42
2017-03-31 $0.00B $0.00B 0.37
2016-12-31 $0.00B $0.00B 2.04
2016-09-30 $0.00B $0.00B 165.70
2016-06-30 $0.00B $0.00B 2.69
2016-03-31 $0.00B $0.00B 0.60
2015-12-31 $0.00B $0.00B 0.37
2015-09-30 $0.00B $0.01B 0.45
2015-06-30 $0.01B $-0.01B -1.12
2015-03-31 $0.01B $-0.01B -1.13
2014-12-31 $0.01B $-0.01B -1.16
2014-09-30 $0.01B $0.00B -1.32
2014-06-30 $0.00B $0.00B -1.30
2014-03-31 $0.00B $0.00B -1.60
2013-12-31 $0.00B $0.00B -1.18
2013-09-30 $0.00B $0.00B -1.53
2013-06-30 $0.00B $0.00B -1.13
2013-03-31 $0.00B $0.00B -1.29
2012-12-31 $0.00B $0.00B -1.11
2012-09-30 $0.00B $0.00B -1.20
2012-06-30 $0.00B $0.00B -1.17
2012-03-31 $0.00B $0.00B -1.12
2011-12-31 $0.00B $0.00B -1.17
2011-09-30 $0.00B $0.00B -1.11
2011-06-30 $0.00B $0.00B -1.10
2011-03-31 $0.00B $0.00B -1.22
2010-12-31 $0.00B $0.00B -1.08
2010-09-30 $0.00B $0.00B -1.09
2010-06-30 $0.00B $0.00B -1.10
2010-03-31 $0.00B $0.00B -1.11
2009-12-31 $0.00B $0.00B -1.12
2009-09-30 $0.00B $0.00B -1.18
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.621B 58.04
Tempus AI (TEM) United States $12.054B 0.00
Doximity (DOCS) United States $12.025B 53.35
Hims & Hers Health (HIMS) United States $10.818B 89.50
IRhythm Technologies (IRTC) United States $5.361B 0.00
Hinge Health (HNGE) United States $4.529B 0.00
Inspire Medical Systems (INSP) United States $2.584B 37.98
Privia Health (PRVA) United States $2.580B 191.09
Phreesia (PHR) United States $1.705B 0.00
Enovis (ENOV) United States $1.691B 8.94
10x Genomics (TXG) United States $1.671B 0.00
Azenta (AZTA) United States $1.471B 64.16
Schrodinger (SDGR) United States $1.456B 0.00
Omnicell (OMCL) United States $1.440B 27.74
Clover Health Investments (CLOV) United States $1.333B 0.00
Claritev (CTEV) United States $1.157B 0.00
Evolent Health (EVH) United States $1.053B 0.00
Fulgent Genetics (FLGT) United States $0.666B 0.00
Veradigm (MDRX) United States $0.509B 0.00
Zepp Health (ZEPP) Netherlands $0.504B 0.00
Standard BioTools (LAB) United States $0.498B 0.00
Talkspace (TALK) United States $0.432B 129.00
Carlsmed (CARL) $0.365B 0.00
Butterfly Network (BFLY) United States $0.357B 0.00
TruBridge (TBRG) United States $0.300B 52.66
Outset Medical (OM) United States $0.235B 0.00
Health Catalyst (HCAT) United States $0.227B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.210B 0.00
KORU Medical Systems (KRMD) United States $0.199B 0.00
CapsoVision (CV) United States $0.189B 0.00
MDxHealth SA (MDXH) Belgium $0.130B 0.00
American Well (AMWL) United States $0.112B 0.00
CareCloud (CCLD) United States $0.108B 4.90
EUDA Health Holdings (EUDA) Singapore $0.095B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.070B 0.00
Pulmonx (LUNG) United States $0.063B 0.00
111 (YI) China $0.054B 0.00
P3 Health Partners (PIII) United States $0.051B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Precipio (PRPO) United States $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.019B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.007B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00